A detailed history of Iag Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Iag Wealth Partners, LLC holds 1,269 shares of ABBV stock, worth $222,557. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,269
Previous 1,096 15.78%
Holding current value
$222,557
Previous $187,000 33.69%
% of portfolio
0.05%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $28,344 - $34,484
173 Added 15.78%
1,269 $250,000
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $10,370 - $12,110
-67 Reduced 5.76%
1,096 $187,000
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $67,923 - $77,392
425 Added 57.59%
1,163 $211,000
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $10,044 - $11,312
-73 Reduced 9.0%
738 $114,000
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $5,610 - $6,495
42 Added 5.46%
811 $120,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $397 - $494
3 Added 0.39%
769 $103,000
Q1 2023

Apr 25, 2023

SELL
$144.61 - $166.54 $4,772 - $5,495
-33 Reduced 4.13%
766 $122,000
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $5,809 - $6,966
-42 Reduced 4.99%
799 $129,000
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $11,407 - $13,084
85 Added 11.24%
841 $113,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $3,440 - $4,374
25 Added 3.42%
756 $116,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $5,411 - $6,713
41 Added 5.94%
731 $118,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $322 - $407
3 Added 0.44%
690 $93,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $10,852 - $12,319
102 Added 17.44%
687 $75,000
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $10,836 - $12,072
103 Added 21.37%
585 $66,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $204 - $225
2 Added 0.42%
482 $53,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $160 - $217
2 Added 0.42%
480 $52,000
Q3 2020

Feb 11, 2021

BUY
$85.91 - $100.83 $15,979 - $18,754
186 Added 63.7%
478 $42,000
Q2 2020

Feb 11, 2021

SELL
$73.37 - $98.18 $660 - $883
-9 Reduced 2.99%
292 $29,000
Q1 2020

Feb 11, 2021

BUY
$64.5 - $97.79 $129 - $195
2 Added 0.67%
301 $23,000
Q4 2019

Feb 11, 2021

BUY
$72.13 - $90.25 $21,566 - $26,984
299 New
299 $27,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iag Wealth Partners, LLC Portfolio

Follow Iag Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iag Wealth Partners, LLC with notifications on news.